Gujarat Develops Region-Specific Anti-Venom
Analysis based on 7 articles · First reported Jul 05, 2026 · Last updated Jul 05, 2026
This development is expected to positively impact the healthcare and pharmaceutical sectors in India, particularly in India — Gujarat, by reducing snakebite fatalities and improving public health outcomes. The success of this region-specific anti-venom could also spur similar initiatives in other regions, creating new market opportunities for pharmaceutical companies like Vins Bioproducts Limited.
India — Gujarat has taken a significant step towards developing its own region-specific anti-snake venom to combat snakebite deaths. The Snake Research Institute, operating under the India — Gujarat Forestry Research Foundation, has supplied lyophilised venom from four major local snake species to Telangana-based M/s Vins Bioproducts Limited for manufacturing. This initiative, led by Chief Minister Bhupendrabhai Patel and supported by Minister Arjun Modhwadia, aims to produce the first batch of anti-venom within a year. The region-specific approach is crucial because snake venom varies geographically, making generic anti-venoms less effective. This effort aligns with India's National Action Plan for Prevention and Control of Snakebite Envenoming, launched by Prime Minister Narendra Modi, which targets a 50% reduction in snakebite deaths by 2030, in line with World Health Organization guidelines. Officials like SK Srivastava and D. C. Patel emphasize the public health significance, noting that snakebites cause a high number of fatalities in India.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard